Tower Research Capital (TRC)’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.7K	Buy	11,675 +1,484	+15%	+$6.27K	﹤0.01%	2757
2025 Q4	$28K	Buy	10,191 +3,317	+48%	+$9.46K	﹤0.01%	2851
2025 Q3	$23.6K	Sell	6,874 -2,520	-27%	-$9.19K	﹤0.01%	3155
2025 Q2	$32.3K	Sell	9,394 -266	-3%	-$702	﹤0.01%	3345
2025 Q1	$20.6K	Buy	9,660 +3,951	+69%	+$11.9K	﹤0.01%	2934
2024 Q4	$18.2K	Buy	5,709 +3,509	+160%	+$28.6K	﹤0.01%	3265
2024 Q3	$29.4K	Buy	+2,200	New	+$29.3K	﹤0.01%	3014
2024 Q2	–	Sell	-1,088	Closed	-$12.9K	–	5710
2024 Q1	$12.9K	Sell	1,088 -839	-44%	-$7.15K	﹤0.01%	3431
2023 Q4	$7.75K	Buy	1,927 +522	+37%	+$1.47K	﹤0.01%	4584
2023 Q3	$3.85K	Buy	1,405 +283	+25%	+$1.32K	﹤0.01%	4946
2023 Q2	$7.5K	Buy	1,122 +452	+67%	+$2.74K	﹤0.01%	4563
2023 Q1	$4K	Sell	670 -1,481	-69%	-$6.05K	﹤0.01%	5055
2022 Q4	$5K	Buy	+2,151	New	+$7.09K	﹤0.01%	4841
2022 Q2	–	Sell	-1,380	Closed	-$5K	–	6095
2022 Q1	$5K	Buy	1,380 +572	+71%	+$2.09K	﹤0.01%	5025
2021 Q4	$3K	Buy	+808	New	+$4.31K	﹤0.01%	5424
2021 Q3	–	Sell	-96	Closed	-$1K	–	5789
2021 Q2	$1K	Sell	96 -347	-78%	-$3.04K	﹤0.01%	5180
2021 Q1	$5K	Sell	443 -3,560	-89%	-$53.8K	﹤0.01%	4653
2020 Q4	$18K	Buy	+4,003	New	+$17.7K	﹤0.01%	3927
2016 Q1	–	Sell	-482	Closed	-$5K	–	4164
2015 Q4	$5K	Sell	482 -754	-61%	-$9.39K	﹤0.01%	2939
2015 Q3	$17K	Buy	1,236 +262	+27%	+$3.78K	﹤0.01%	1867
2015 Q2	$14K	Buy	974 +236	+32%	+$3.82K	﹤0.01%	2399
2015 Q1	$12K	Buy	738 +408	+124%	+$6.06K	﹤0.01%	2622
2014 Q4	$5K	Buy	+330	New	+$5.23K	﹤0.01%	2684
2014 Q2	–	Sell	-40	Closed	-$1K	–	4057
2014 Q1	$1K	Buy	+40	New	+$407	﹤0.01%	4114